Cardiotoxicity and Cardiac Monitoring During Adjuvant Trastuzumab in Daily Dutch Practice: A Study of the Southeast Netherlands Breast Cancer Consortium

INTRODUCTION. We assessed the incidence and timing of first cardiac events, impact on trastuzumab prescription, and role of left ventricular ejection fraction (LVEF) monitoring in daily practice of trastuzumab-treated patients with human epidermal growth receptor 2 (HER2)-positive early breast cance...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncologist
Auteurs principaux: Seferina, Shanly C., de Boer, Maaike, Derksen, M. Wouter, van den Berkmortel, Franchette, van Kampen, Roel J.W., van de Wouw, Agnès J., Joore, Manuela, Peer, Petronella G.M., Voogd, Adri C., Tjan-Heijnen, Vivianne C.G.
Format: Artigo
Langue:Inglês
Publié: AlphaMed Press 2016
Sujets:
Breast Cancer
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4861356/
https://ncbi.nlm.nih.gov/pubmed/27009939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0230
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires